Found: 37
Select item for more details and to access through your institution.
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent.
- Published in:
- Pharmacogenomics Journal, 2014, v. 14, n. 2, p. 151, doi. 10.1038/tpj.2013.17
- By:
- Publication type:
- Article
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
- Published in:
- Pharmacogenomics Journal, 2009, v. 9, n. 4, p. 258, doi. 10.1038/tpj.2009.14
- By:
- Publication type:
- Article
EXPERIMENTAL RICKETS.
- Published in:
- Acta Paediatrica, 1931, v. 12, n. S1, p. 7, doi. 10.1111/j.1651-2227.1931.tb05275.x
- By:
- Publication type:
- Article
Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 90, n. 5, p. 693, doi. 10.1038/clpt.2011.174
- By:
- Publication type:
- Article
The Emerging Role of Electronic Medical Records in Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 379, doi. 10.1038/clpt.2010.260
- By:
- Publication type:
- Article
Estrogen Receptor Genotypes, Menopausal Status, and the Effects of Tamoxifen on Lipid Levels: Revised and Updated Results.
- Published in:
- Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 5, p. 626, doi. 10.1038/clpt.2010.143
- By:
- Publication type:
- Article
Clinically Available Pharmacogenomics Tests.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 86, n. 1, p. 109, doi. 10.1038/clpt.2009.39
- By:
- Publication type:
- Article
Estrogen Receptor Genotypes, Menopausal Status, and the Lipid Effects of Tamoxifen.
- Published in:
- Clinical Pharmacology & Therapeutics, 2008, v. 83, n. 5, p. 702, doi. 10.1038/sj.clpt.6100343
- By:
- Publication type:
- Article
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 81, n. 3, p. 328, doi. 10.1038/sj.clpt.6100087
- By:
- Publication type:
- Article
OIV-B-3.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P34, doi. 10.1016/j.clpt.2005.12.120
- By:
- Publication type:
- Article
PII-18.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P40, doi. 10.1016/j.clpt.2005.12.143
- By:
- Publication type:
- Article
PII-21.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P42, doi. 10.1016/j.clpt.2005.12.146
- By:
- Publication type:
- Article
PIII-34.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P67, doi. 10.1016/j.clpt.2005.12.242
- By:
- Publication type:
- Article
PI-24.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P13, doi. 10.1016/j.clpt.2005.12.045
- By:
- Publication type:
- Article
PI-29.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P15, doi. 10.1016/j.clpt.2005.12.050
- By:
- Publication type:
- Article
ER-alpha and ER-beta genotypes predict tamoxifen effects on serum lipids in breast cancer patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P2, doi. 10.1016/j.clpt.2003.11.005
- By:
- Publication type:
- Article
Gene expression profiles of 4-hydroxy-N-desmethyl-tamoxifen (endoxifen)- and 4-hydroxy-tamoxifen (4OHTAM)-treated human breast cancer cells determined by CDNA microarray analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P49, doi. 10.1016/j.clpt.2003.11.183
- By:
- Publication type:
- Article
The association between the CYP3A5 genotype and blood pressure.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P61, doi. 10.1016/j.clpt.2003.11.233
- By:
- Publication type:
- Article
The association between CYP3A5 genotype and antihypertensive response.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P62, doi. 10.1016/j.clpt.2003.11.234
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacogenetics predict the inhibitory effects of tamoxifen on platelet aggregation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P67, doi. 10.1016/j.clpt.2003.11.251
- By:
- Publication type:
- Article
CYP genotypes influence the effect of tamoxifen therapy on serum lipids.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P69, doi. 10.1016/j.clpt.2003.11.261
- By:
- Publication type:
- Article
Pharmacological characterization of 4-hydroxy-n-desmethyl-tamoxifen (ENDOXIFEN) AND 4-hydroxy-tamoxifen (4OHTAM).
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P19, doi. 10.1016/j.clpt.2003.11.073
- By:
- Publication type:
- Article
Pharmacogenetic Predictors of Tamoxifen Effect on Bone Mineral Density.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P42, doi. 10.1016/S0009-9236(03)90513-3
- By:
- Publication type:
- Article
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 1, p. 277, doi. 10.1007/s10549-017-4400-8
- By:
- Publication type:
- Article
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 9, p. 2331, doi. 10.1038/bjc.2013.587
- By:
- Publication type:
- Article
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 3, p. 307, doi. 10.1038/clpt.2014.101
- By:
- Publication type:
- Article
Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 96, n. 2, p. 175, doi. 10.1038/clpt.2014.62
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update.
- Published in:
- Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 4, p. 376, doi. 10.1038/clpt.2013.254
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 5, p. 402, doi. 10.1038/clpt.2013.2
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 2, p. 321, doi. 10.1038/clpt.2011.287
- By:
- Publication type:
- Article
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 863, doi. 10.1007/s00280-011-1556-5
- By:
- Publication type:
- Article
Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects.
- Published in:
- Neurogastroenterology & Motility, 2008, v. 20, n. 8, p. 891, doi. 10.1111/j.1365-2982.2008.01124.x
- By:
- Publication type:
- Article
Insulin-like growth factor (IGF)-I and -II and IGF binding proteins in serum and mammary secretions during the dry period and early lactation in dairy cows
- Published in:
- Journal of Animal Science, 1991, v. 69, n. 6, p. 2538
- By:
- Publication type:
- Article
Serotonin and cognitive dysfunction in breast cancer survivors.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
The role of serotonin in hot flashes after breast cancer.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis.
- Published in:
- 1999
- By:
- Publication type:
- journal article